EUVIMEDEUVIMED entdecken
Crossref

Supramolecular Matrine-Proanthocyanidins Nanocomplex-Integrated Carboxymethyl Chitosan Hydrogel with Phenylboronic Acid Modification for Atopic Dermatitis Therapy

Zijian Zeng, Jiahui Meng, Jiangchuan He, Weijia Pan, Yunhe Zheng iD, Yanbo Xue, Nan Wang iD, Ke Wang iD

ACS Applied Materials & Interfaces · 16.11.2026

DOI: 10.1021/acsami.6c16342 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 16.11.2026. Verfasst von Zijian Zeng und 7 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Xi'an Jiaotong University, 76 Yanta West Street, Xi'an710061, China. Die Arbeit nennt 42 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Research and Development Projects of Shaanxi Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atopic dermatitis (AD) is a chronic inflammatory skin disease featured by immune dysregulation, oxidative stress, and an impaired epidermal barrier. Oxidative stress and inflammation establish a self-sustaining vicious cycle that accelerates the progression of atopic dermatitis. However, few naturally derived self-assembled nanohydrogels have been developed to disrupt this reciprocal loop for the treatment of cutaneous AD. In this study, matrine (MAT) and proanthocyanidins (PAC), two Chinese medicine-derived molecules with inherent antioxidant and anti-inflammatory activities, co-assembled spontaneously into nanoparticles (PM NPs) in aqueous solution. Incorporation of PM NPs into the phenylboronic acid-modified carboxymethyl chitosan (CP) crosslinked network enhanced the mechanical strength of carboxymethyl chitosan, forming a composite hydrogel (CPPM). Spectral results verified that PM NP self-assembly was mediated by hydrogen bonding and π-π stacking. CPPM efficiently scavenged reactive oxygen species (ROS), suppressed the activation of the Ox-CaMKII and NF-κB signaling pathways, and activated Nrf2 to restore epidermal redox homeostasis. CPPM exhibited favorable moisturizing capacity, appropriate rheological properties, and mild ROS-triggered release to realize local therapeutic effects. In 1-chloro-2,4-dinitrochlorobenzene (DNCB)-induced AD mice, topical CPPM application significantly alleviated epidermal hyperplasia, itching, and inflammatory cytokine expression without obvious toxicity. This self-assembled bioactive hydrogel can concurrently regulate oxidative stress and inflammatory responses, offering a promising topical therapeutic approach against AD.

Schlagwörter

Stichwörter der Autor:innen

antioxidantatopic dermatitiscarboxymethyl chitosanmatrinenanoparticlesproanthocyanidins

Autor:innen und Institutionen

  • School of Pharmacy, Xi'an Jiaotong University, 76 Yanta West Street, Xi'an710061, China.
  • Department of Cardiology, The First Affiliated Hospital of Xi'an Jiaotong University, 277 Yanta West Street, Xi'an710061, Shaanxi, China.

ORCID-Profile: Yunhe Zheng, Nan Wang, Ke Wang

Förderung

  • National Natural Science Foundation of China
  • Key Research and Development Projects of Shaanxi Province

Zitieren

APA

Zeng, Z., Meng, J., He, J., Pan, W., Zheng, Y., Xue, Y., Wang, N., & Wang, K. (2026). Supramolecular Matrine-Proanthocyanidins Nanocomplex-Integrated Carboxymethyl Chitosan Hydrogel with Phenylboronic Acid Modification for Atopic Dermatitis Therapy. ACS Applied Materials & Interfaces. https://doi.org/10.1021/acsami.6c16342

Vancouver

Zeng Z, Meng J, He J, Pan W, Zheng Y, Xue Y, et al. Supramolecular Matrine-Proanthocyanidins Nanocomplex-Integrated Carboxymethyl Chitosan Hydrogel with Phenylboronic Acid Modification for Atopic Dermatitis Therapy. ACS Applied Materials & Interfaces. 2026. doi:10.1021/acsami.6c16342

BibTeX
@article{Zeng2026,
  author = {Zeng, Zijian and Meng, Jiahui and He, Jiangchuan and Pan, Weijia and Zheng, Yunhe and Xue, Yanbo and Wang, Nan and Wang, Ke},
  title = {Supramolecular Matrine-Proanthocyanidins Nanocomplex-Integrated Carboxymethyl Chitosan Hydrogel with Phenylboronic Acid Modification for Atopic Dermatitis Therapy},
  journal = {ACS Applied Materials & Interfaces},
  year = {2026},
  doi = {10.1021/acsami.6c16342}
}
Kostenlos starten →